Selected passages from the FDA letter
Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.
Passage 1Failure to adequately establish procedures for corrective and preventive action, as required by 21 CFR 820.100(a). For example,
Passage 2Failure to adequately establish and maintain procedures for validating the device design, as required by 21 CFR 820.30(g). For example:
Passage 3Failure to include a copy of all communications regarding the correction or removal in the report, as required by 21 CFR 806.10(c)(12). For example, you included a paragraph in the customer notification letter sent to consignees for an open recall (Z-1764-2025) that was omitted from the version of the letter sent to the FDA as part of the written report.
Citations in the original letter
As cited in this historical letter, not a statement of current regulatory requirements.
- 21 CFR 806.10(c)(12)
- 21 CFR 806
- 21 CFR 820.100(a)
- 21 CFR 820.30(g)
- 21 CFR 820.198(a)
- 21 CFR 820.180